Yoshiaki Maru

906 total citations
26 papers, 702 citations indexed

About

Yoshiaki Maru is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Yoshiaki Maru has authored 26 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Yoshiaki Maru's work include Cancer Cells and Metastasis (12 papers), Renal and related cancers (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Yoshiaki Maru is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Renal and related cancers (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Yoshiaki Maru collaborates with scholars based in Japan, United Kingdom and United States. Yoshiaki Maru's co-authors include Yoshitaka Hippo, Makiko Itami, Naotake Tanaka, Hiroki Nagase, Masako Ochiai, Toshio Imai, Miki Ohira, Tatsuo Kanda, Fumio Imazeki and Hiromitsu Saisho and has published in prestigious journals such as Nature Communications, Hepatology and International Journal of Cancer.

In The Last Decade

Yoshiaki Maru

23 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Maru Japan 14 346 257 161 131 96 26 702
Patricia Roxburgh United Kingdom 14 491 1.4× 296 1.2× 178 1.1× 61 0.5× 44 0.5× 50 754
Lorna Rodrı́guez-Rodrı́guez United States 14 271 0.8× 489 1.9× 75 0.5× 110 0.8× 44 0.5× 39 876
Martina Breidenbach Germany 18 316 0.9× 338 1.3× 146 0.9× 65 0.5× 58 0.6× 35 914
Chi-Mu Chuang Taiwan 15 118 0.3× 215 0.8× 112 0.7× 101 0.8× 73 0.8× 21 576
Lingfei Han China 16 223 0.6× 286 1.1× 34 0.2× 135 1.0× 78 0.8× 36 724
Yeh Chen Lee Australia 13 318 0.9× 253 1.0× 227 1.4× 138 1.1× 91 0.9× 51 791
Fang Xiong China 11 489 1.4× 522 2.0× 79 0.5× 243 1.9× 33 0.3× 12 1.2k
Hoa Nguyen United States 9 124 0.4× 229 0.9× 176 1.1× 46 0.4× 74 0.8× 23 490
Liying Gu China 15 96 0.3× 271 1.1× 26 0.2× 156 1.2× 61 0.6× 35 609
Clorinda Annunziata Italy 12 147 0.4× 286 1.1× 11 0.1× 227 1.7× 100 1.0× 16 647

Countries citing papers authored by Yoshiaki Maru

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Maru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Maru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Maru more than expected).

Fields of papers citing papers by Yoshiaki Maru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Maru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Maru. The network helps show where Yoshiaki Maru may publish in the future.

Co-authorship network of co-authors of Yoshiaki Maru

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Maru. A scholar is included among the top collaborators of Yoshiaki Maru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Maru. Yoshiaki Maru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imai, Toshio, Rikako Ishigamori, Mie Naruse, et al.. (2024). Bridging toxicological properties of environmental chemicals between animals and humans using healthy organoid systems. The Journal of Toxicological Sciences. 49(10). 425–434.
2.
Maru, Yoshiaki, Kiyomi Suzuka, Mari Masuda, et al.. (2024). Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer. Human Cell. 37(3). 840–853. 5 indexed citations
3.
Maru, Yoshiaki, Yuki Nakamura, Yasutoshi Tatsumi, et al.. (2022). Derivation of pancreatic acinar cell carcinoma cell line HS‐1 as a patient‐derived tumor organoid. Cancer Science. 114(3). 1165–1179. 6 indexed citations
4.
Ishigamori, Rikako, Mie Naruse, Akihiro Hirata, et al.. (2022). The potential of organoids in toxicologic pathology: Histopathological and immunohistochemical evaluation of a mouse normal tissue-derived organoid-based carcinogenesis model. Journal of Toxicologic Pathology. 35(3). 211–223. 2 indexed citations
5.
Kato, Shingo, Yuichiro Yabuki, Yoshiaki Maru, et al.. (2021). Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds. Oncogenesis. 10(4). 33–33. 18 indexed citations
6.
Maru, Yoshiaki & Yoshitaka Hippo. (2021). Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives. Frontiers in Genetics. 12. 798628–798628. 7 indexed citations
7.
Maru, Yoshiaki, Naotake Tanaka, Yasutoshi Tatsumi, et al.. (2021). Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition. Oncogenesis. 10(6). 46–46. 15 indexed citations
8.
Sugiyama, Takahiro, et al.. (2021). A case of cervical clear cell carcinoma with serous component. Journal of obstetrics and gynaecology research. 47(7). 2551–2554.
9.
Naruse, Mie, et al.. (2020). An organoid-based carcinogenesis model induced by in vitro chemical treatment. Carcinogenesis. 41(10). 1444–1453. 25 indexed citations
10.
Maru, Yoshiaki, Naotake Tanaka, Makiko Itami, & Yoshitaka Hippo. (2019). Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors. Gynecologic Oncology. 154(1). 189–198. 124 indexed citations
11.
Ochiai, Masako, Yoshiaki Maru, Tetsuya Matsuura, et al.. (2019). Kras-driven heterotopic tumor development from hepatobiliary organoids. Carcinogenesis. 40(9). 1142–1152. 26 indexed citations
12.
Matsuura, Tetsuya, Yoshiaki Maru, Masashi Izumiya, et al.. (2019). Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis. Carcinogenesis. 41(4). 490–501. 23 indexed citations
13.
Maru, Yoshiaki, et al.. (2019). Establishment and characterization of patient‐derived organoids from a young patient with cervical clear cell carcinoma. Cancer Science. 110(9). 2992–3005. 44 indexed citations
14.
Noguchi, Rei, Kiyoshi Yamaguchi, Tsuneo Ikenoue, et al.. (2017). Genetic alterations in Japanese extrahepatic biliary tract cancer. Oncology Letters. 14(1). 877–884. 11 indexed citations
15.
Maru, Yoshiaki, et al.. (2016). Lentivirus-Based Stable Gene Delivery into Intestinal Organoids. Methods in molecular biology. 1422. 13–21. 38 indexed citations
16.
Maru, Yoshiaki, Naotake Tanaka, Miki Ohira, et al.. (2016). Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis. Gynecologic Oncology. 144(2). 377–383. 48 indexed citations
17.
Inoue, Takahiro, Takayoshi Watanabe, Nobuko Koshikawa, et al.. (2015). Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole–imidazole polyamide conjugate. Nature Communications. 6(1). 6706–6706. 80 indexed citations
18.
Maru, Yoshiaki, et al.. (2013). Cytology of endobronchial ultrasound-guided transbronchial needle aspiration. The Journal of the Japanese Society of Clinical Cytology. 52(4). 295–303.
19.
Tajiri, Hisao, Makoto Muto, Atsushi Ohtsu, et al.. (1999). Clinical Significance of Magnetic Resonance Cholangiopancreatography for the Diagnosis of Cystic Tumor of the Pancreas Compared with Endoscopic Retrograde Cholangiopancreatography and Computed Tomography. Japanese Journal of Clinical Oncology. 29(6). 294–298. 13 indexed citations
20.
Kanda, Tatsuo, Osamu Yokosuka, Toshiki Ehata, et al.. (1997). Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology. 25(5). 1261–1265. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026